BAYER HEALTHCARE LLC has filed 12 insider transactions across 2 companies since February 2024.
Most recent transaction: a transaction of 2222000 shares of Senti Biosciences, Inc. ($SNTI) on March 10, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2025 | Senti Biosciences, Inc. | $SNTI | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 2222000 | $0.00 | 2,809,848.0000 | 4,829,035 | 377.99% | 46.01% |
| March 10, 2025 | Senti Biosciences, Inc. | $SNTI | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A Convertible Preferred Stock | 2222 | $0.00 | 0.0000 | 4,829,035 | 100.00% | 0.05% |
| Dec. 9, 2024 | Senti Biosciences, Inc. | $SNTI | BAYER HEALTHCARE LLC | TenPercentOwner | P | Series A Convertible Preferred Stock | 2222 | $0.00 | 2,222.0000 | 4,586,957 | 9999.99% | 0.05% |
| Dec. 9, 2024 | Senti Biosciences, Inc. | $SNTI | BAYER HEALTHCARE LLC | TenPercentOwner | P | Warrant | 3333000 | $0.00 | 3,330,000.0000 | 4,586,957 | 0.00% | 72.66% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 1770888 | $0.00 | 1,770,888.0000 | 3,884,740 | 9999.99% | 45.59% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 1180592 | $0.00 | 2,951,480.0000 | 3,884,740 | 66.67% | 30.39% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 589662 | $0.00 | 3,541,142.0000 | 3,884,740 | 19.98% | 15.18% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 509855 | $0.00 | 4,050,997.0000 | 3,884,740 | 14.40% | 13.13% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A-1 Convertible Preferred Stock | 3093580 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 79.63% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A-4 Convertible Preferred Stock | 2062387 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 53.09% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series B Convertible Preferred Stock | 1030086 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 26.52% |
| Feb. 13, 2024 | Metagenomi Therapeutics, Inc. | $MGX | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series B-1 Convertible Preferred Stock | 890671 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 22.93% |